Symptoms, risks and treatment of corneal stromal dystrophy are explained in detail by the Corneal & External Eye Disease Department at Singapore National Eye Centre (SNEC).
Corneal stromal dystrophy: Symptoms
In corneal stromal dystrophy, the gene causes an abnormal accumulation of protein on the cornea – the transparent layer in front of the eye. It appears as white dots and as these increase, there will be a gradual loss of vision.
Patients will experience varying degrees of cloudiness of the cornea and blurred vision. The disease can cause pain and discomfort as lumps protrude on the surface of the cornea. In the worst case scenario, a corneal transplant is usually the only recourse to regain vision. However, the disease can recur in the new cornea post-transplant.
Sometimes, cloudiness of the cornea may be due to other, less severe causes such as contact lens wear,
viral conjunctivitis, injuries or diminishing cells in the cornea with age but this is not severe enough to need a transplant.
Corneal disease - Risks and Treatment
Increased risks among Asians
Corneal stromal dystrophy is common in Asia and a significant contributor to blindness.
Every year, SNEC surgeons do about 10 transplants on people with this disease.
Treatment: Corneal transplant
“They are the ones who have it bad enough to need transplants. But if you look at the real number of patients, it’s about four times that amount, and we’re not even talking about family members. It’s not going to become an epidemic but it is a significant problem in the population,” shared the
Corneal & External Eye Disease Department from the Singapore National Eye Centre (SNEC), a member of the
Those with a mild form may not need a corneal transplant, but severe cases will. Tests help eye surgeons determine what type of transplant to do, and whether the patient will need another operation in the future.
The Corneal & External Eye Disease Department said, “We do various types of transplants. We can now detect which mutations can occur and know that certain mutations have a higher risk of the disease recurring. We can tailor this to the needs of the patient. If there is a chance of the disease recurring or that the patient may need a second operation, we won’t replace the whole cornea, just a partial one, so it will be easier the second time around.”
Although corneal transplants are the only recourse presently, researchers are actively investigating the disease. “We are also looking at possible new treatments, where in the future, we can develop eye drops linked to the gene to prevent development of the disease,” said the Corneal & External Eye Disease Department.
Click on page 1 to learn more about the
Singapore-made blood test that can detect corneal disease early.